# Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients

> **NCT03120832** · PHASE1 · COMPLETED · sponsor: **Sensei Biotherapeutics, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** PAN-301-1

## Key facts

- **NCT ID:** NCT03120832
- **Lead sponsor:** Sensei Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120832, "Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03120832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*